CWClovis P. Wouters

Clovis P. Wouters

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Clovis P. Wouters has a total of 29 co-authors. Here are the top co-authors by number of shared publications:

  • Dominique-Marie Votion

    Department of Functional Sciences, Faculty of Veterinary Medicine, Pharmacology and Toxicology, Fundamental and Applied Research for Animals & Health (FARAH), University of Liège, 4000 Liège, Belgium

    4 shared publications
  • Anne-Christine François

    Department of Functional Sciences, Faculty of Veterinary Medicine, Pharmacology and Toxicology, Fundamental and Applied Research for Animals & Health (FARAH), University of Liège, 4000 Liège, Belgium

    3 shared publications
  • Benoît Renaud

    Department of Functional Sciences, Faculty of Veterinary Medicine, Pharmacology and Toxicology, Fundamental and Applied Research for Animals & Health (FARAH), University of Liège, 4000 Liège, Belgium

    3 shared publications
  • François Boemer

    CHU Liege, 4000 Liège, Belgium

    3 shared publications
  • Caroline-Julia Kruse

    Department of Functional Sciences, Faculty of Veterinary Medicine, Physiology and Sport Medicine, Fundamental and Applied Research for Animals & Health (FARAH), University of Liège, 4000 Liège, Belgium

    2 shared publications
  • Anne-Christine François

    Service of Pharmacology and Toxicology, Department of Functional Sciences, Fundamental and Applied Research for Animals & Health (FARAH), Faculty of Veterinary Medicine, University of Liège, Sart Tilman, 4000 Liège, Belgium

    1 shared publication

Latest Publications

  • Metabolomic/Lipidomic investigations in equine atypical myopathy and in vitro screening of non-pharmaceutical compounds

    by Clovis Wouters

    Investigations métabolomiques/lipidomiques de la myopathie atypique équine et criblage in vitro de composés non pharmaceutiques: La myopathie atypique est une rhabdomyolyse sévère causée par l’ingestion de toxines retrouvées dans l’environnement des chevaux. Dans la même pâture, tous les chevaux ne manifestent pas les signes cliniques de la maladie, malgré la présence de toxines dans leur sang. Le premier but de la thèse était d’améliorer la compréhension physiopathologique de la maladie en investiguant le métabolome sanguin des chevaux. Une étude comparant le métabolome de chevaux symptomatiques et asymptomatiques provenant de la même pâture a identifié quarante-six métabolites qui appartiennent majoritairement à la classe chimique des acides gras et acides aminés. Cette étude révèle des changements métaboliques caractéristiques dans le sang des chevaux cliniquement affectés et identifie plusieurs voies métaboliques perturbées (i.e. métabolisme des lipides, des acides aminés ramifiés et de la glycine). De surcroı̂t, cinq de ces métabolites ont montré une valeur pronostique potentielle. Ensuite, une étude préliminaire se concentrant sur les lipides sanguins a révélé le potentiel de la lipidomique dans la compréhension de la maladie. D’autre part, sur base de la caractérisation du métabolome, l’objectif subséquent était de contribuer au développement d’un complément alimentaire visant à prévenir l’occurrence de la maladie. Pour se faire, un modèle d’intoxication in vitro a été développé permettant le criblage haut débit de composés non-pharmaceutiques. Dans ces expériences, une réponse cytotoxique ”tout ou rien” a été observée avec des concentrations de métabolites toxiques très proches. Le métabolite toxique déclenche la mort cellulaire par apoptose. Plusieurs composés non-pharmaceutiques ont montré un effet in vitro protecteur potentiel. Ensemble, ces résultats améliorent la compréhension de la physiopathologie de la MA et contribueront potentiellement à mieux détecter, pronostiquer et gérer la myopathie atypique.

  • Open Access

    Unravelling Faecal Microbiota Variations in Equine Atypical Myopathy: Correlation with Blood Markers and Contribution of Microbiome

    by Anne-Christine François, Carla Cesarini, Bernard Taminiau, Benoît Renaud, Caroline-Julia Kruse, François Boemer, Gunther van Loon, Katrien Palmers, Georges Daube, Clovis P. Wouters, et al.

    Hypoglycin A and methylenecyclopropylglycine are protoxins responsible for atypical myopathy in equids. These protoxins are converted into toxins that inhibit fatty acid β-oxidation, leading to blood accumulation of acylcarnitines and toxin conjugates, such as methylenecyclopropylacetyl-carnitine. The enzymes involved in this activation are also present in some prokaryotic cells, raising questions about the potential role of intestinal microbiota in the development of intoxication. Differences have been noted between the faecal microbiota of cograzers and atypical myopathy-affected horses. However, recent blood acylcarnitines profiling revealed subclinical cases among cograzers, challenging their status as a control group. This study investigates the faecal microbiota of horses clinically affected by atypical myopathy, their cograzers, and a control group of toxin-free horses while analysing correlations between microbiota composition and blood parameters. Faecal samples were analysed using 16S amplicon sequencing, revealing significant differences in α-diversity, evenness, and β-diversity. Notable differences were found between several genera, especially Clostridia_ge, Bacteria_ge, Firmicutes_ge, Fibrobacter, and NK4A214_group. Blood levels of methylenecyclopropylacetyl-carnitine and C14:1 correlated with variations in faecal microbial composition. The theoretical presence of enzymes in bacterial populations was also investigated. These results underscore the critical need to investigate the potential role of intestinal microbiota in this poisoning and may provide insights for developing prevention and treatment strategies.


  • Open Access

    A Zebrafish Embryo Model to Screen Potential Therapeutic Compounds in Sapindaceae Poisoning

    by Clovis P. Wouters, Benjamin Klein, Nicholas Price, François Boemer, Marianne L. Voz, Dominique-Marie Votion

    Hypoglycin A (HGA) and methylenecyclopropylglycine (MCPrG) are protoxins produced by Sapindaceae plants, particularly Acer pseudoplatanus, and are responsible for causing atypical myopathy (AM) in equids. These protoxins metabolise into toxic compounds, such as methylenecyclopropylacetyl-CoA (MCPA-CoA), which alters energy metabolism and induces severe rhabdomyolysis. Currently, no specific treatment exists for this poisoning, in vitro models fail to reproduce HGA’s toxic effects on equine primary myoblasts, and mammalian models are impractical for large-scale drug screening. This study aimed to develop a zebrafish embryo model for screening therapeutic compounds against AM. Zebrafish embryos were exposed to various concentrations of HGA, MCPrG, and methylenecyclopropylacetate (MCPA) for 72 h. MCPrG did not induce toxicity, while HGA and MCPA showed median lethal concentration (LC50) values of 1.7 µM and 1 µM after 72 h, respectively. The highest levels of the conjugated metabolite MCPA–carnitine were detected 24 h after HGA exposure, and the acylcarnitines profile was highly increased 48 h post-exposure. Isovaleryl-/2- methylbutyrylcarnitine levels notably rose after 24 h, suggesting potential exposition biomarkers. Glycine and carnitine effectively reduced mortality, whereas riboflavin showed no protective effect. These findings suggest that the zebrafish embryo represents a valuable model for identifying therapeutic compounds for Sapindaceae poisoning.


  • Open Access

    Tissue Specific Distribution and Activation of Sapindaceae Toxins in Horses Suffering from Atypical Myopathy

    by Johannes Sander, Michael Terhardt, Nils Janzen, Benoît Renaud, Caroline-Julia Kruse, Anne-Christine François, Clovis P. Wouters, François Boemer, Dominique-Marie Votion

    Equine atypical myopathy is caused by hypoglycin A (HGA) and methylenecyclopropylglycine (MCPrG), the known protoxins of sycamore maple (Acer pseudoplatanus). Various tissues from five atypical myopathy cases were analyzed but only HGA was found. Whether deamination of MCPrG has already occurred in the intestine as the first stage of metabolization has not been investigated. Activation of the protoxins to methylenecyclopropylacetyl (MCPA)-CoA and methylenecyclopropylformyl (MCPF)-CoA, respectively, occurred mainly in the skeletal muscles, as evidenced by very high concentrations of MCPA-carnitine and MCPF-carnitine in this tissue. Inhibition of the acyl-CoA dehydrogenases of short- and medium-chain as well as branched-chain fatty acids by the toxins led to a strong increase in the corresponding acylcarnitines, again preferentially in skeletal muscles. An accumulation of the long-chain acylcarnitines beyond the level of the control samples could not be detected in the tissues. As a high amount of HGA was always found unmetabolized in the organs, we speculate that targeting the interruption of further metabolization might be a way to stop the progression of intoxication. Inhibition of the mitochondrial branched-chain amino acid aminotransferase, i.e., the first enzyme responsible for the activation of sycamore maple protoxins, could be a therapeutic approach.


  • Open Access

    Pasture Management to Reduce the Risk of Acer pseudoplatanus Poisoning While Preserving Ecological Sustainability

    by Barbara Ghislain, Arnaud Farinelle, Benoît Renaud, Anne-Christine François, Clovis P. Wouters, Dominique-Marie Votion

    In spring, grazing equids may suffer from a severe rhabdomyolysis syndrome named atypical myopathy. This environmental intoxication results from ingestion of toxins contained in Acer pseudoplatanus seedlings. The aim of this study was to investigate the effectiveness of herbicide spraying and mowing to reduce the toxic pressure of sycamore seedlings. In a first experiment, the efficacy of three herbicides to eradicate seedlings was compared to mowing. In a second experiment, the influence of the mowing timing on pasture productivity was determined. In both experiments, sycamore seedling counting, grass height and botanical composition were determined. In experiment 2, the final harvest biomass and its nutritional value were also determined. Herbicides and mowing both reduced the number of seedlings, which nevertheless disappear naturally over time without intervention (i.e., in control areas). As opposed to mowing, herbicide spraying altered the composition of the pasture flora. Both sprayed and mowed seedlings remain toxic until full decomposition. Early mowing (i.e., early April) did not affect the harvest yield. Late mowing (i.e., end of April) reduced the harvest yield but its nutritional value fitted the horses’ need. In conclusion, mowing is the best strategy to reduce the risk of Acer pseudoplatanus poisoning in grazing equids while preserving ecological sustainability and nutritional value of pastures.


  • Metabolomic Signatures Discriminate Horses with Clinical Signs of Atypical Myopathy from Healthy Co-grazing Horses

    by Clovis P. Wouters, Marie-Pierre Toquet, Benoit Renaud, Anne-Christine François, Justine Fortier-Guillaume, Christel Marcillaud-Pitel, François Boemer, Pascal De Tullio, Eric A. Richard, Dominique-Marie Votion

    Atypical myopathy (AM) is a severe rhabdomyolysis syndrome that occurs in grazing horses. Despite the presence of toxins in their blood, all horses from the same pasture are not prone to display clinical signs of AM. The objective of this study was to compare the blood metabolomic profiles of horses with AM clinical signs with those of healthy co-grazing (Co-G) horses. To do so, plasma samples from 5 AM horses and 11 Co-G horses were investigated using untargeted metabolomics. Metabolomic data were evaluated using unsupervised, supervised, and pathway analyses. Unsupervised principal component analysis performed with all detected features separated AM and healthy Co-G horses. Supervised analyses had identified 1276 features showing differential expression between both groups. Among them, 46 metabolites, belonging predominantly to the fatty acid, fatty ester, and amino acid chemical classes, were identified by standard comparison. Fatty acids, unsaturated fatty acids, organic dicarboxylic acids, and fatty esters were detected with higher intensities in AM horses in link with the toxins’ pathological mechanism. The main relevant pathways were lipid metabolism; valine, leucine, and isoleucine metabolism; and glycine metabolism. This study revealed characteristic metabolite changes in the plasma of clinically affected horses, which might ultimately help scientists and field veterinarians to detect and manage AM. The raw data of metabolomics are available in the MetaboLights database with the access number MTBLS2579.